[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100545886":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":20,"locations":21,"responsibleParty":42,"collaborators":44,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":20,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":20,"overallStatus":24,"whyStopped":20,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"University Hospital, Antwerp","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Investigational Arm","EXPERIMENTAL","Single arm study protocol",[13],"Device: Hepatoscope",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Hepatoscope","The Hepatoscope is a non-invasive external ultrasound imaging device, intended for general purpose pulse echo ultrasound imaging, and soft tissue elasticity imaging of the human body. In addition, the Hepatoscope provides measurements of shear wave speed and tissue stiffness, ultrasound beam attenuation and estimates of speed of sound, in internal structures of the body.",[9],null,[22],{"facility":23,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Universitair Ziekenhuis Antwerpen","RECRUITING","Edegem","Antwerp","2650","Belgium","BE",{"type":31,"coordinates":32},"Point",[33,34],4.44504,51.15662,{"lat":34,"lon":33},[37],{"name":38,"role":39,"phone":40,"phoneExt":20,"email":41},"Luisa Vonghia, MD - PhD","CONTACT","003238213323","studies.hepatologie@uza.be",{"type":43,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR",[45],{"name":46,"class":47},"E-Scopics","INDUSTRY","100545886","referral-of-patients-to-hepatology-with-hepatoscope-100545886",false,"NCT06387745","Referral of Patients to Hepatology With Hepatoscope","Use of Ultrasound Tools to Refer Patients at Risk of Chronic Liver Disease to the Hepatology Consultation (US-REFERRAL)","US-REFERRAL","Inclusion Criteria:\n\n* Patients with any of the following\n\n  * Elevated liver enzymes (AST, ALT, Gamma-GT, AP)\n  * Type 2 diabetes\n  * Elements of metabolic syndrome\n* Patients who consent in written to participate in the Clinical Investigation after being orally informed on the objectives and methods of the Clinical Investigation\n\nExclusion Criteria:\n\n* Patients with active implants such as pacemakers, defibrillators, pumps, etc.\n* Patients presenting wounds at the location where the Hepatoscope probe shall be placed on patients' skin,\n* Pregnant and breastfeeding women,\n* People deprived of their freedom rights.","ALL","18 Years","80 Years",{"count":60,"type":61},200,"ESTIMATED","INTERVENTIONAL",[64],"NA","Patients identified as being at risk of liver fibrosis because of a positive Fibrosis-4 (FIB-4) test in the primary care setting will be offered be enrolled in the trial and to undergo an Hepatoscope exam (external non-invasive ultrasound imaging exam) to screen for liver fibrosis (with stiffness measurements) and\u002For steatosis (with ultrasound parameters related to fatty liver). All patients presenting with a liver stiffness value of at least 6.5 kilopascal (kPa) will be referred to the tertiary hepatology consultations for further assessment. Hepatoscope measurements will be compared to the standard of care for these patients, as defined at the tertiary hepatology center.",[67],"Chronic Liver Disease","2026-05-04",{"date":70,"type":71},"2026-05-08","ACTUAL",{"date":73,"type":71},"2025-08-22",{"date":75,"type":61},"2026-12",{"name":5,"class":6},1]